Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE filing · raw filing ↗
12 Aug 2026
⚑ Filing
Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE filing · raw filing ↗
10 Aug 2026
⚑ Filing
Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE filing · raw filing ↗
10 Aug 2026
⚑ Result
Kwality Pharmaceuticals Ltd - 539997 - Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations, 2015BSE filing · raw filing ↗
10 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹162 Cr (+45.6% YoY), PAT ₹26 Cr (+115.0% YoY)BSE filing · raw filing ↗
9 Aug 2026
⚑ Filing
Kwality Pharmaceuticals Ltd - 539997 - Notice Convening The 43Rd Annual General Meeting ("AGM") Of The Company On Monday, 31St August, 2026 At 12 :00 Noon. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OA VM).BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
